OA10094A - N,n'-substituted imidocarbonimidic diamides derived from hydroxylamines - Google Patents

N,n'-substituted imidocarbonimidic diamides derived from hydroxylamines Download PDF

Info

Publication number
OA10094A
OA10094A OA60554A OA60554A OA10094A OA 10094 A OA10094 A OA 10094A OA 60554 A OA60554 A OA 60554A OA 60554 A OA60554 A OA 60554A OA 10094 A OA10094 A OA 10094A
Authority
OA
OAPI
Prior art keywords
group
carbon atoms
mono
compound
substituted
Prior art date
Application number
OA60554A
Other languages
English (en)
Inventor
Craig Canfield
David P Jacobus
Neil J Lewis
Original Assignee
Jacobus Pharmaceutical Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jacobus Pharmaceutical Company filed Critical Jacobus Pharmaceutical Company
Publication of OA10094A publication Critical patent/OA10094A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/13—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Paints Or Removers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Seasonings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
OA60554A 1992-02-14 1994-08-12 N,n'-substituted imidocarbonimidic diamides derived from hydroxylamines OA10094A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/837,258 US5322858A (en) 1992-02-14 1992-02-14 N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines

Publications (1)

Publication Number Publication Date
OA10094A true OA10094A (en) 1996-12-18

Family

ID=25273975

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60554A OA10094A (en) 1992-02-14 1994-08-12 N,n'-substituted imidocarbonimidic diamides derived from hydroxylamines

Country Status (25)

Country Link
US (1) US5322858A (ko)
EP (1) EP0625967B1 (ko)
JP (1) JP3207200B2 (ko)
KR (1) KR950700243A (ko)
CN (1) CN1057520C (ko)
AT (1) ATE157352T1 (ko)
AU (1) AU668709B2 (ko)
CA (1) CA2129430C (ko)
CZ (1) CZ294257B6 (ko)
DE (1) DE69313438T2 (ko)
DK (1) DK0625967T3 (ko)
EG (1) EG20476A (ko)
ES (1) ES2108862T3 (ko)
FI (1) FI943738A (ko)
GR (1) GR3025429T3 (ko)
HU (1) HU220389B (ko)
IL (1) IL104484A (ko)
MX (1) MX9300688A (ko)
NO (1) NO302616B1 (ko)
NZ (1) NZ245865A (ko)
OA (1) OA10094A (ko)
PL (2) PL173258B1 (ko)
RU (1) RU2133737C1 (ko)
WO (1) WO1993016037A1 (ko)
ZA (1) ZA93974B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4321444A1 (de) * 1993-06-28 1995-01-05 Bernd Prof Dr Clement Pharmazeutische Zubereitung
US6551614B2 (en) 2001-03-14 2003-04-22 Jacobus Pharmaceutical Co., Inc. Antimalarial N,N′-substituted biguanides derived from hydroxylamines
CA2477604A1 (en) 2002-03-13 2003-09-25 Signum Biosciences, Inc. Modulation of protein methylation and phosphoprotein phosphate
CN1738794B (zh) * 2002-11-22 2010-12-22 雅各布斯制药公司 双胍和二氢三嗪衍生物
US7256218B2 (en) * 2002-11-22 2007-08-14 Jacobus Pharmaceutical Company, Inc. Biguanide and dihydrotriazine derivatives
WO2006084033A1 (en) * 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
EP2194985B1 (en) 2007-10-08 2019-02-20 MMV Medicines for Malaria Venture Antimalarial compounds with flexible side-chains
KR20100098602A (ko) * 2007-10-13 2010-09-08 코넬 유니버시티 마이코박테리움 아비움 아종 파라투베르쿨로시스에 대한 면역 응답을 유발하기 위한 조성물
CA2758424C (en) 2008-04-21 2018-03-06 Signum Biosciences, Inc. Tryptamine derivatives as pp2a methylation modulators
BRPI0908701A2 (pt) * 2008-05-09 2015-07-21 Tolmar Inc Composição, método para o tratamento de uma doença ou distúrbio de pelo ou mucosa, método para o tratamento de acne, método de extermínio ou inibição do crescimento de bactérias, protozoários ou fungos e uso de proguanil
US10829440B2 (en) 2015-06-12 2020-11-10 Brown University Antibacterial compounds and methods of making and using same
US11261157B2 (en) 2016-12-08 2022-03-01 Novatarg, Inc. Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy
US11555010B2 (en) 2019-07-25 2023-01-17 Brown University Diamide antimicrobial agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB603070A (en) * 1946-01-25 1948-06-08 Albert Frederick Crowther Manufacture of biguanide derivatives
GB665680A (en) * 1948-02-20 1952-01-30 Rhone Poulenc Sa Improvements in or relating to the production of n-p-chlorophenyl-n-isopropyl biguanide
DE824942C (de) * 1949-01-31 1951-12-17 Ici Ltd Verfahren zur Herstellung von Biguanidderivaten
GB667116A (en) * 1949-04-25 1952-02-27 Albert Frederick Crowther Manufacture of biguanide derivatives
GB814563A (en) * 1956-11-15 1959-06-10 Vitamins Ltd Biguanides
GB1270831A (en) * 1968-11-22 1972-04-19 Beecham Group Ltd Di-hydro triazine derivatives and processes for their manufacture
GB1250531A (ko) * 1969-01-01 1971-10-20
US3723429A (en) * 1969-11-06 1973-03-27 Beecham Group Ltd Di-hydro triazine derivatives
US3660394A (en) * 1970-01-23 1972-05-02 Vitamins Ltd 4 6-dibenzo-1 2-dihydro-aryloxy-1 3 5-triazines

Also Published As

Publication number Publication date
NO942988L (no) 1994-10-05
ES2108862T3 (es) 1998-01-01
HU220389B (hu) 2002-01-28
PL172001B1 (pl) 1997-07-31
AU3475993A (en) 1993-09-03
NO942988D0 (no) 1994-08-12
RU94039539A (ru) 1997-05-27
HU9401976D0 (en) 1994-09-28
DK0625967T3 (da) 1998-03-23
EP0625967A1 (en) 1994-11-30
FI943738A0 (fi) 1994-08-12
CA2129430C (en) 2004-04-06
CA2129430A1 (en) 1993-08-15
MX9300688A (es) 1993-08-01
EG20476A (en) 1999-05-31
JPH07503730A (ja) 1995-04-20
IL104484A (en) 1998-07-15
US5322858A (en) 1994-06-21
ZA93974B (en) 1993-09-14
NO302616B1 (no) 1998-03-30
RU2133737C1 (ru) 1999-07-27
DE69313438D1 (de) 1997-10-02
CN1076689A (zh) 1993-09-29
IL104484A0 (en) 1993-05-13
ATE157352T1 (de) 1997-09-15
KR950700243A (ko) 1995-01-16
CZ196494A3 (en) 1995-10-18
FI943738A (fi) 1994-10-12
HUT68802A (en) 1995-07-28
GR3025429T3 (en) 1998-02-27
JP3207200B2 (ja) 2001-09-10
EP0625967B1 (en) 1997-08-27
WO1993016037A1 (en) 1993-08-19
CN1057520C (zh) 2000-10-18
CZ294257B6 (cs) 2004-11-10
NZ245865A (en) 1996-02-27
AU668709B2 (en) 1996-05-16
PL173258B1 (pl) 1998-02-27
DE69313438T2 (de) 1998-03-19

Similar Documents

Publication Publication Date Title
OA10094A (en) N,n'-substituted imidocarbonimidic diamides derived from hydroxylamines
AU692892B2 (en) Enzyme inhibitors
KR920021523A (ko) 신규한 우레아 유도체, 이의 제조 방법 및 이들을 함유하는 약제학적 조성물
CZ412898A3 (cs) Substituované cyklopentanové sloučeniny, použitelné jako inhibitory neuraminidázy
US4732916A (en) Novel guanidinomethylbenzoic acid derivatives
US4115448A (en) Carbamylguanidine antimicrobial compounds
US4618622A (en) Sulfonates of hydroxycoumarins
DE68912020T2 (de) N-2,3-Butadienyl-tri-aminoalkanderivate.
US5268500A (en) Compound, composition and method for the reduction of lipids the modification of the affinity of hemoblogin for oxygen and the prevention of platelet aggregation
ES2090024T3 (es) Compuestos de cefemo y procedimientos para su preparacion.
HU195486B (en) Process for preparing new pyridine derivatives
GB1585963A (en) Aryl sulphur compounds
Foye et al. Antiradiation Compounds. IV. Trithiocarbonates of β-Mercaptoethylguanidines1
PT98684A (pt) Processo de preparacao de derivados da difenilureia e de composicoes farmaceuticas contendo os mesmos
PL128998B1 (en) Process for preparing novel 2-amino-3-benzoylphenylacetamides and their derivatives
KR960029319A (ko) 4-아미노벤조일구아니딘 유도체
FR2525221A1 (fr) Derives du furanne et sels d'addition de ces derives, leurs procedes de preparation et leurs applications en therapeutique
US4514390A (en) Melaminylthioarsenites
Gump et al. Adrenergic blocking agents. I. N-(2-chloroethyl)-dibenzylamine series
US5658952A (en) 1-[4-(4'-sulfanilyl)phenyl]urea and derivatives for the treatment of Leishmaniasis
CZ20012482A3 (cs) Deriváty ((aminoiminomethyl)amino)alkankarboxamidu a jejich pouľití v terapii
US3454640A (en) Alkoxy- or alkylthio-alkyleneaminoalkylguanidines
US3531499A (en) 3,4-alkylene-dioxybenzyl biguanides
GB2030137A (en) 5-alkynylamino (thioalkyl containing) imidazoles
Willson et al. Biological properties of amidinium sulfinic and sulfonic acid derivatives: inhibition of glycolytic enzymes of Trypanosoma brucei and protective effect on cell growth